<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Only a few doses of compassionate use investigational antiviral treatments were available. Two patients received ZMAb and towards the end of the outbreak, Goderich ETC took part in the Prevail II trial [
 <xref ref-type="bibr" rid="CR8">8</xref>], randomizing five patients to standard care plus ZMapp (two patients) versus standard care alone (three patients). Based on the available preclinical literature suggesting in vitro and in vivo efficacy [
 <xref ref-type="bibr" rid="CR24">24</xref>], a randomised clinical trial protocol was developed to investigate the efficacy of treatment of EVD with amiodarone. The trial was registered at ClinicalTrials.gov (NCT02307591) (see Supplementary material S4 for details).
</p>
